跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 632 条关于
“Spark LS”
全部
632
临床试验
262
药物
102
机构
24
资讯
244
去年
Coriolis Pharma Invests $10 Million in North Carolina Laboratory to Expand Biopharmaceutical Development Services
2年前
Durvalumab Improves Survival in Limited-Stage Small Cell Lung Cancer Subgroups
2个月前
RIO Trial: Long-Acting bNAbs 3BNC117-LS and 10-1074-LS Delay HIV Rebound and Accelerate Reservoir Decay After Treatment Interruption
去年
Durvalumab Shifts Decades Long SOC as First FDA-Approved Immunotherapy Regimen in LS-SCLC
去年
NRG Oncology/Alliance LU005 Trial: Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
3个月前
UVA Joins SPARK GLOBAL to Accelerate Translation of Academic Discoveries into New Medicines
去年
TheraSyn Bio and Rubix LS Launch Joint Venture to Develop Novel Topical Breast Cancer Therapy
4个月前
Spark Biomedical Appoints Anja Krammer as CEO to Drive Bioelectronic Medicine Platform Forward
2年前
Spark Biomedical Receives NIDA Funding to Develop AI for Opioid Withdrawal Detection
去年
Kiffik Biomedical and Rubix LS Join Forces to Develop Novel Non-Invasive Colorectal Cancer Test
第 1 页,共 25 页
上一页
下一页